EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana

Benjamin Abuaku, Paul Boateng, Nana Yaw Peprah, Alexander Asamoah, Nancy Odurowah Duah-Quashie, Sena Adzoa Matrevi, Eunice Obeng Amoako, Neils Quashie, Felicia Owusu-Antwi, Keziah Laurencia Malm, Kwadwo Ansah Koram

Frontiers in Cellular and Infection Microbiology · 06.01.2023 · 12

DOI: 10.3389/fcimb.2022.1058660 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.01.2023. Verfasst von Benjamin Abuaku und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Malaria, Falciparum. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Global Fund to Fight AIDS, Tuberculosis and Malaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2020, Dihydroartemisinin-Piperaquine (DHAP) was adopted as a second-line antimalarial for treatment of uncomplicated malaria in Ghana following a review of the country’s antimalarial medicines policy. Available data obtained in 2007 had shown PCR-uncorrected therapeutic efficacy of 93.3% using a 28-day follow-up schedule. In 2020, the standard 42-day follow-up schedule for DHAP was used to estimate efficacy levels among febrile children aged 6 months to 9 years in three malaria sentinel sites representing the three main ecological zones of the country- savannah, forest, and coastal. PCR genotyping distinguished between recrudescence and re-infection using merozoite surface protein 2 (MSP2)-specific primers for FC27 and 3D7 strains. Per protocol analyses showed day 28 efficacy of 100% in all three sentinel sites with day 42 PCR-corrected efficacy ranging between 90.3% (95% CI: 80.1 – 96.4%) in the savannah zone and 100% in the forest and coastal zones, yielding a national average of 97.0% (95% CI: 93.4 – 98.8). No day 3 parasitemia was observed in all three sites. Prevalence of measured fever (axillary temperature ≥ 37.5°C) declined from 50.0 - 98.8% on day 0 to 7.1-11.5% on day 1 whilst parasitemia declined from 100% on day 0 to 1.2 - 2.3% on day 1. Mean haemoglobin levels on days 28 and 42 were significantly higher than pre-treatment levels in all three sites. We conclude that DHAP is highly efficacious in the treatment of uncomplicated malaria in Ghana. This data will serve as baseline for subsequent DHAP efficacy studies in the country.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaMalaria, FalciparumChildHumansGhanaParasitemiaDrug CombinationsTreatment OutcomeArtemisininsPiperazinesQuinolines

Stichwörter der Autor:innen

Ghanadihydroartemisinin-piperaquineefficacytreatmentuncomplicated malaria

Substanzen

AntimalarialsDrug CombinationsartenimolArtemisininspiperaquinePiperazinesQuinolines

Autor:innen und Institutionen

  • Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
  • National Malaria Elimination Program, Public Health Division, Ghana Health Service, Accra, Ghana.
  • Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, Accra, Ghana.
  • Country Office, World Health Organization, Accra, Ghana.

Förderung

  • World Health Organization
  • Global Fund to Fight AIDS, Tuberculosis and Malaria

Zitieren

APA

Abuaku, B., Boateng, P., Peprah, N. Y., Asamoah, A., Duah-Quashie, N. O., Matrevi, S. A., Amoako, E. O., Quashie, N., Owusu-Antwi, F., Malm, K. L., & Koram, K. A. (2023). Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.1058660

Vancouver

Abuaku B, Boateng P, Peprah NY, Asamoah A, Duah-Quashie NO, Matrevi SA, et al. Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana. Frontiers in Cellular and Infection Microbiology. 2023;12. doi:10.3389/fcimb.2022.1058660

BibTeX
@article{Abuaku2023,
  author = {Abuaku, Benjamin and Boateng, Paul and Peprah, Nana Yaw and Asamoah, Alexander and Duah-Quashie, Nancy Odurowah and Matrevi, Sena Adzoa and Amoako, Eunice Obeng and Quashie, Neils and Owusu-Antwi, Felicia and Malm, Keziah Laurencia and Koram, Kwadwo Ansah},
  title = {Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {12},
  doi = {10.3389/fcimb.2022.1058660}
}
Kostenlos starten →